Comparing two PET scans for neuroendocrine tumors
Part of Cancer clinical trials.
This study compares two types of PET/CT scans to see which one is better at finding and staging neuroendocrine tumors. If you qualify, you will get both scans, which may help your doctor plan your treatment more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are already scheduled for a standard PET/CT scan to check for a suspected or known neuroendocrine tumor.
- You are not pregnant or breastfeeding.
- You are willing and able to have a second PET/CT scan.
- You weigh less than 204.5 kg and can fit into the scanner opening (70 cm wide).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a PET/CT scan with a small amount of radioactive tracer to see how neuroendocrine tumors are behaving in adults. It may help doctors better detect and evaluate these tumors, especially when symptoms suggest a carcinoid-type hormone problem.
This trial tests a new PET scan tracer to find neuroendocrine tumors in the body. It may help doctors see where the tumors are and plan better treatment.
This trial tests a new type of PET scan using a radioactive tracer called 61Cu-NODAGA-LM3 to detect neuroendocrine tumors (NETs). The goal is to see if it works as well as or better than the standard scan. If you have a NET and need a scan for staging or treatment planning, you might be able to join.
This trial tests a special PET scan to better evaluate gastroenteropancreatic neuroendocrine tumors (GEP-NETs). It may help your doctor see where the tumors are in your body.
This study tests a new type of PET scan that uses a special tracer (a radioactive substance) to find neuroendocrine tumors. The scan may help detect these tumors more clearly, which can guide treatment decisions.
This trial tests a new type of PET/CT scan called [68Ga]Ga-FAPI-04 to see if it can better detect high-grade neuroendocrine tumors. It is for patients whose standard scans show low uptake or who have aggressive tumor features.
Hear when a new Neuroendocrine Tumors, NET trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.